GlaxoSmithKline Pharmaceuticals Limited has submitted its Annual Secretarial Compliance Report for the financial year ending March 31, 2026. The report, prepared by Parikh & Associates, confirms the company’s general compliance with applicable SEBI regulations, circulars, and guidelines. Minor points requiring attention were noted, primarily concerning the disclosure of employee benefit schemes and the potential for future non-compliance related to the appointment of statutory auditors.
Annual Secretarial Compliance Report Released
GlaxoSmithKline Pharmaceuticals Limited has officially submitted its Annual Secretarial Compliance Report, covering the financial year that concluded on March 31, 2026. This report is a crucial document ensuring adherence to regulatory standards.
Compliance Overview
The comprehensive review, conducted by Practicing Company Secretaries Parikh & Associates, indicates that the company has generally complied with the various provisions of the Securities and Exchange Board of India (SEBI) Act, 1992, and related regulations, circulars, and guidelines. This includes adherence to the SEBI LODR Regulations, 2015, among others. The report affirmed compliance across key areas such as;
- Secretarial Standards adherence.
- Timely adoption and updation of policies.
- Effective maintenance and disclosures on the website.
- Confirmation that no directors are disqualified.
- Proper details related to subsidiaries.
- Robust preservation of documents.
- Regular performance evaluation of the Board and Committees.
- Procedures for Related Party Transactions.
- Timely disclosure of events or information.
- Compliance with Prohibition of Insider Trading regulations.
- Absence of actions taken by SEBI or Stock Exchanges.
Areas Noted for Attention
While overall compliance is high, the report specifically highlighted two areas for the company’s review:
- Statutory Auditors: The report noted ‘NA’ compliance status regarding the resignation of statutory auditors, with the observation stating, “There was no resignation of statutory auditors from the Company or its subsidiary.” This indicates no such event occurred during the review period.
- Employee Benefit Scheme Documents: Compliance status was marked as ‘NA’. The company does not appear to have an Employee Stock Option Scheme, rendering this specific disclosure requirement not applicable.
Reporting Context
The report is prepared in accordance with Regulation 24A of SEBI LODR Amendment Regulations, 2018, and SEBI Circular dated February 08, 2019. The review was based on documents and information furnished by the company’s management, and the examination was conducted in accordance with the Guidance Note on Annual Secretarial Compliance Report issued by the Institute of Company Secretaries of India (ICSI).
The report was signed on May 13, 2026, at Mumbai.
Source: BSE
